文献速递消化道肿瘤与早癌消化内镜

多次阴性粪便免疫化学检测降低结肠镜监测项目中的进展期肿瘤风险

Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-01-05

该回顾性队列研究纳入3369例50-74岁接受结肠镜监测的个体,共4021个监测间期,评估1-4轮粪便免疫化学检测(FIT)阴性(<20 μg血红蛋白/g粪便)与随访结肠镜检出进展期肿瘤风险的关系。进展期肿瘤发生率为9.9%,随阴性FIT轮数增加而降低,3轮和4轮阴性FIT者的风险显著低于仅1轮阴性者。

要点

  • 在平均风险以上接受结肠镜监测的人群中,多次阴性FIT与进展期肿瘤风险降低相关。
  • 3轮和4轮阴性FIT者进展期肿瘤风险显著低于仅1轮阴性FIT者。
  • 作者认为间隔期FIT可用于个体化监测,在多次阴性FIT后延长结肠镜间隔。

核心结论

  • 在既往结肠镜无肿瘤或仅有非进展期腺瘤的平均风险以上人群中,多轮阴性FIT后进展期肿瘤风险较低。
  • 作者认为该结果支持使用间隔期FIT来个体化监测,在多次阴性FIT结果后延长结肠镜间隔。

研究设计与样本

  • 回顾性队列研究,纳入3369例50-74岁个体,共4021个监测间期。
  • 个体在两次结肠镜之间完成2样本FIT,每1-2年1轮,共1-4轮,每轮结果均为阴性(<20 μg血红蛋白/g粪便)。
  • 在随访结肠镜时确定进展期肿瘤(结直肠癌或进展期腺瘤)的发生率,采用竞争风险回归评估2年内多次阴性FIT与进展期肿瘤风险的关联。

主要发现

  • 队列中进展期肿瘤发生率为9.9%。
  • 进展期肿瘤发生率随阴性FIT轮数增加而降低:1轮阴性FIT后为11.1%,4轮阴性FIT后为5.7%。
  • 与仅1轮阴性FIT相比,3轮阴性FIT者进展期肿瘤风险显著降低(亚分布风险比0.50;95%CI 0.24-0.97)。
  • 与仅1轮阴性FIT相比,4轮阴性FIT者进展期肿瘤风险显著降低(亚分布风险比0.33;95%CI 0.15-0.73)。

临床怎么用

  • 作者认为,在既往结肠镜无肿瘤或仅有非进展期腺瘤的平均风险以上人群中,间隔期FIT可用于个体化监测,在多次阴性FIT结果后延长结肠镜间隔。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In above-average-risk individuals undergoing colonoscopy-based surveillance for colorectal cancer (CRC), screening with fecal immunochemical tests (FIT) between colonoscopies might facilitate personalization of surveillance intervals. Because a negative FIT is associated with a reduced risk for CRC, we examined the relationship between number of rounds of negative FIT and risk for advanced neoplasia in individuals undergoing surveillance colonoscopy. METHODS: We conducted a retrospective cohort study on 4021 surveillance intervals in 3369 individuals (50-74 years), who had completed a 2-sample FIT between colonoscopies, from 1 to 4 rounds at 1-2 yearly intervals, each with a negative result (<20 μg hemoglobin/g feces). Incidence of advanced neoplasia (CRC or advanced adenoma) was determined at the follow-up colonoscopy. Competing-risk regression was used to assess the association between multiple negative FIT results and the risk of advanced neoplasia within 2 years. RESULTS: The incidence of advanced neoplasia in the cohort was 9.9% and decreased with increasing numbers of rounds of negative FIT results: 11.1% after 1 negative FIT to 5.7% after 4 negative FIT. The risk of advanced neoplasia was significantly lower in participants with 3 (subdistribution hazard ratio, 0.50; 95% confidence interval, 0.24-0.97) and 4 (subdistribution hazard ratio, 0.33; 95% confidence interval, 0.15-0.73) rounds of negative FIT compared with only 1 negative FIT. CONCLUSIONS: There was a low risk of advanced neoplasia after multiple rounds of negative FIT in above-average-risk people undergoing surveillance with no neoplasia or nonadvanced adenoma at prior colonoscopy. This supports the use of interval FIT to personalize surveillance by lengthening colonoscopy intervals following multiple negative FIT results.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wassie MM, Young GP, Winter JM, et al. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program. Clin Gastroenterol Hepatol. 2023. PMID: 36610499. doi:10.1016/j.cgh.2022.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。